| Literature DB >> 35359761 |
Jin-Yan Qi1, Gang Zhai1, Yu Wang1, Yuan-Bo Liang2, Dong Li1, Liang Wen1, Dong-Xiao Zang1, Ke-Mi Feng2, Bo Zang1, Cong Xie1.
Abstract
Objective: This study aimed to assess the knowledge, attitude, and practice (KAP) of diabetic subjects with diabetic retinopathy (DR) and those without DR (NDR) in an urban community in Northeast China, as well as their risk factors in subjects with DR and NDR.Entities:
Keywords: Northeast China; attitude; knowledge; practice; urban population
Mesh:
Year: 2022 PMID: 35359761 PMCID: PMC8962192 DOI: 10.3389/fpubh.2022.808988
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
The demographic characteristics of NDR and DR.
|
|
|
| |
|---|---|---|---|
|
|
| ||
| Age (years) | 0.028 | ||
| ≤ 60 | 365 (41.52) | 367 (46.87) | |
| >60 | 514 (58.48) | 416 (53.13) | |
| Gender | 0.289 | ||
| Male | 366 (41.64) | 306 (39.08) | |
| Female | 513 (58.36) | 477 (60.92) | |
| Occupation | 0.232 | ||
| Employment | 101 (11.49) | 87 (11.11) | |
| Unemployment | 52 (5.92) | 63 (8.05) | |
| Retirement | 726 (82.59) | 633 (80.84) | |
| Education | 0.071 | ||
| Primary | 524 (59.61) | 504 (64.37) | |
| Middle | 227 (25.82) | 172 (21.97) | |
| High | 128 (14.56) | 107 (13.67) | |
| Living alone | 0.331 | ||
| Yes | 91 (10.35) | 70 (8.94) | |
| No | 788 (89.65) | 713 (91.06) | |
| Type of treatment | 0.000 | ||
| Oral pills | 646 (73.49) | 453 (57.85) | |
| Insulin | 140 (15.93) | 303 (38.70) | |
| Diet control | 93 (10.58) | 27 (3.45) | |
| Disease duration (years) | 5.76 ± 4.70 | 10.50 ± 6.19 | 0.000 |
| <10 | 702 (79.86) | 344 (43.93) | |
| ≥10 | 177 (20.14) | 439 (56.07) |
P < 0.05 for χ.
NDR, no diabetic retinopathy; DR, diabetic retinopathy.
Multivariate logistic regression of good knowledge in NDR and DR.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| ≤ 60 | 7 (35) | 358 (41.68) | 0.4 (0.1, 1.7) | 0.237 | 4 (23.53) | 363 (47.39) | 0.3 (0.1, 1.2) | 0.096 |
| >60 | 13 (65) | 501 (58.32) | Ref. | Ref. | 13 (76.47) | 403 (52.61) | Ref. | Ref. |
|
| ||||||||
| Male | 9 (45) | 357 (41.56) | 0.6 (0.2, 1.5) | 0.253 | 9 (52.94) | 297 (38.77) | 1.5 (0.5, 4.1) | 0.47 |
| Female | 11 (55) | 502 (58.44) | Ref. | Ref. | 8 (47.06) | 469 (61.23) | Ref. | Ref. |
|
| ||||||||
| Employment | 5 (25) | 96 (11.18) | 0.2 (0.1, 1.1) | 0.067 | 2 (11.74) | 85 (11.10) | 0.8 (0.1, 4.5) | 0.803 |
| Unemployment | 0 | 52 (6.05) | 12,090,101 (0.0, +∞) | 0.998 | 0 | 63 (8.22) | 17,237,851 (0.0, +∞) | 0.997 |
| Retirement | 15 (75) | 711 (82.77) | Ref. | Ref. | 15 (88.23) | 618 (80.68) | Ref. | Ref. |
|
| ||||||||
| Primary | 3 (15) | 521 (60.65) | 0.1 (0.0, 0.2) | <0.001 | 7 (41.18) | 497 (64.88) | 2.8 (0.8, 9.9) | 0.104 |
| Middle | 5 (25) | 222 (25.84) | 0.2 (0.1, 0.6) | 0.005 | 5 (29.41) | 167 (21.80) | 1.5 (0.4, 5.7) | 0.524 |
| High | 12 (60) | 116 (13.5) | Ref. | Ref. | 5 (29.41) | 102 (13.32) | Ref. | Ref. |
|
| ||||||||
| Oral pills | 13 (65) | 633 (73.69) | 0.6 (0.1, 4.8) | 0.620 | 8 (47.06) | 445 (58.09) | 0 (0.0, +∞) | 0.998 |
| Insulin | 6 (30) | 134 (15.60) | 0.3 (0.0, 3.0) | 0.316 | 9 (52.94) | 294 (38.38) | 0 (0.0, +∞) | 0.998 |
| Diet control | 1 (5) | 92 (10.71) | Ref. | Ref. | 0 | 27 (3.53) | Ref. | Ref. |
|
| ||||||||
| <10 | 13 (65) | 689 (80.21) | 0.5 (0.2, 1.4) | 0.202 | 5 (29.41) | 339 (44.26) | 0.8 (0.3, 2.4) | 0.66 |
| ≥10 | 7 (35) | 170 (19.79) | Ref. | Ref. | 12 (70.59) | 427 (55.74) | Ref. | Ref. |
NDR, no diabetic retinopathy; DR, diabetic retinopathy.
Multivariate logistic regression of good attitude in NDR and DR.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| ≤ 60 | 360 (41.62) | 5 (35.71) | 3.0 (0.7, 11.9) | 0.125 | 356 (46.41) | 11 | 0.4 (0.1, 1.2) | 0.102 |
| >60 | 505 (58.38) | 9 (64.29) | Ref. | Ref. | 411 (53.59) | 5 | Ref. | Ref. |
|
| ||||||||
| Male | 359 (41.50) | 7 (50) | 0.9 (0.3, 2.8) | 0.823 | 298 (38.85) | 8 | 0.5 (0.2, 1.6) | 0.263 |
| Female | 506 (58.50) | 7 (50) | Ref. | Ref. | 469 (61.15) | 8 | Ref. | Ref. |
|
| ||||||||
| Employment | 100 (11.56) | 1 (7.14) | 1.3 (0.2, 10.0) | 0.830 | 86 (11.21) | 1 | 0.4 (0.1, 3.8) | 0.452 |
| Unemployment | 48 (5.55) | 4 (28.57) | 0.2 (0.0, 0.5) | 0.002 | 59 (7.69) | 4 | 2.2 (0.6, 8.3) | 0.234 |
| Retirement | 717 (82.89) | 9 (64.29) | Ref. | Ref. | 622 (81.10) | 11 | Ref. | Ref. |
|
| ||||||||
| Primary | 513 (59.30) | 11 (78.57) | 32,047,821 (0.0, +∞) | 0.996 | 490 (63.89) | 14 | 43,510,111 (0.0, +∞) | 0.996 |
| Middle | 224 (25.90) | 3 (21.43) | 21,759,974 (0.0, +∞) | 0.996 | 170 (22.16) | 2 | 17,827,840 (0.0, +∞) | 0.996 |
| High | 128 (14.80) | 0 | Ref. | Ref. | 107 (13.95) | 0 | Ref. | Ref. |
|
| ||||||||
| Oral pills | 637 (73.64) | 9 (64.29) | 1.1 (0.1, 9.6) | 0.902 | 442 (57.63) | 11 | 35,307,911(0.0, +∞) | 0.998 |
| Insulin | 136 (15.72) | 4 (28.57) | 3.5 (0.4, 33.8) | 0.285 | 298 (38.85) | 5 | 19,224,211(0.0, +∞) | 0.998 |
| Diet control | 92 (10.64) | 1 (7.14) | Ref. | Ref. | 27 (3.52) | 0 | Ref. | Ref. |
|
| ||||||||
| <10 | 688 (79.54) | 14 (100) | 0.0 (0.0, +∞) | 0.995 | 338 (44.07) | 6 | 1.8 (0.6, 5.5) | 0.282 |
| ≥10 | 177 (20.46) | 0 | Ref. | Ref. | 429 (55.93) | 10 | Ref. | Ref. |
NDR, no diabetic retinopathy; DR, diabetic retinopathy.
Multivariate logistic regression of good practice in NDR and DR.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| ≤ 60 | 261 (40.03) | 104 (45.81) | 0.8 (0.6, 1.1) | 0.212 | 264 (43.28) | 103 (59.54) | 0.6 (0.4, 0.9) | 0.023 |
| >60 | 391 (59.97) | 123 (54.19) | Ref. | Ref. | 346 (56.72) | 70 (40.46) | Ref. | Ref. |
|
| ||||||||
| Male | 250 (38.34) | 116 (51.1) | 0.5 (0.4, 0.7) | <0.001 | 229 (37.54) | 77 (44.51) | 0.8 (0.6, 1.2) | 0.344 |
| Female | 402 (61.66) | 111 (48.9) | Ref. | Ref. | 381 (62.46) | 96 (55.49) | Ref. | Ref. |
|
| ||||||||
| Employment | 69 (10.58) | 32 | 1.0 (0.6, 1.7) | 0.964 | 61 (10) | 26 (15.03) | 0.7 (0.4, 1.2) | 0.166 |
| Unemployment | 35 (5.37) | 17 | 1.2 (0.6, 2.3) | 0.558 | 37 (6.07) | 26 (15.03) | 0.4 (0.2, 0.8) | 0.005 |
| Retirement | 548 (84.05) | 178 | Ref. | Ref. | 512 (83.93) | 121 (69.94) | Ref. | Ref. |
|
| ||||||||
| Primary | 371 (56.9) | 153 (67.4) | 0.4 (0.2, 0.6) | <0.001 | 388 (63.61) | 116 (67.05) | 1.8 (1.0, 3.3) | 0.074 |
| Middle | 175 (26.84) | 52 (22.91) | 0.6 (0.3, 1.0) | 0.054 | 132 (21.64) | 40 (23.12) | 1.8 (0.9, 3.4) | 0.093 |
| High | 106 (16.26) | 22 (9.69) | Ref. | Ref. | 90(14.75) | 17(9.83) | Ref. | Ref. |
|
| ||||||||
| Oral pills | 489 (75) | 157 (69.16) | 2.3 (1.4, 3.6) | 0.001 | 356 (58.36) | 97 (56.07) | 0.9 (0.4, 2.3) | 0.828 |
| Insulin | 111 (17.02) | 29 (12.78) | 3.1 (1.7, 5.6) | <0.001 | 234 (38.36) | 69 (39.88) | 0.9 (0.3, 2.3) | 0.803 |
| Diet control | 52 (7.98) | 41 (18.06) | Ref. | Ref. | 20(3.28) | 7(4.05) | Ref. | Ref. |
| <10 | 521 (79.91) | 181 | 1.3 (0.9, 1.9) | 0.242 | 269 (44.10) | 75 (43.35) | 1.2 (0.8, 1.7) | 0.422 |
| ≥10 | 131 (20.09) | 46 | Ref. | Ref. | 341 (55.90) | 98 (56.65) | Ref. | Ref. |
NDR, no diabetic retinopathy; DR, diabetic retinopathy.